CDC kicks off annual flu shot drive
WASHINGTON — The Centers for Disease Control and Prevention joined the National Foundation for Infectious Disease, along with other public health and medical groups, on Thursday to kick off the 2017-18 flu vaccination campaign.
"While we don't know what this season has in store, the science on flu vaccination is clear," stated Health and Human Services Secretary Tom Price, who recieved his flu shot during the press conference announcing the campaign. "Today, I am leading by example and getting vaccinated against flu. I urge everyone six months and older to do the same as soon as vaccine is available in their community."
Influenza vaccination coverage last year across the entire U.S. population was 46.8%, an increase of 1.2 percentage points from the previous season. That level of coverage meant that more than half of the U.S. population was unprotected against flu last season.
Among children 6 months through 17 years, coverage with one or more doses of flu vaccine was 59%, similar to the 2015–16 season (59.3%). Coverage was 43.3% among adults over the age of18 years, which was 1.6 percentage points higher than coverage during the 2015–16 season (41.7%).
"We are pleased to see that the decrease in vaccination coverage among adults age 50 years and older that we saw in the 2015-2016 season was not sustained during the 2016-2017 season," commented Kathleen Neuzil, director of the Center for Vaccine Development at the University of Maryland School of Medicine. "It is critical to maintain the hightest level of vaccination coverage for older adults because they are disproportionally affected by flu. Vaccination not only reduces chance that older adults will get the flu, it can also keep them out of the hospital by reducing the severity of the infection and related complications if they do get the flu."
Ritzman broadens scope of ‘Ritzman Revives’ program
MEDINA, Ohio — As an answer to a dated, commoditized pharmacy experience, Ritzman Pharmacy is launching new products and services to better align with the actual role pharmacists play in the lives and wellness of patients with a series of comprehensive wellness assessments, the Ohio retailer announced Friday.
“Fifty years ago, the primary role of pharmacists was solely to dispense prescriptions. They were not permitted to discuss medications with patients and had to refer them back to their physicians when questions arose,” noted John Dimmick, Ritzman Pharmacist, noting that's no longer the case. “Our healthcare landscape and patients’ needs are changing, and pharmacists are no longer simply dispensing medication. Our pharmacists are also providing important wellness and healthcare services through innovative programs and services across our practice settings. Our purpose is to help people get, stay and live well [and] to transform them and the role community pharmacy plays in healthcare.”
Building on the already launched Ritzman Revives program, select Ritzman Pharmacy locations will offer comprehensive wellness assessments. The program will support customers in answering wellness questions, such as how can they get more energy or how can they lose weight.
Customers can come in anytime or schedule their free wellness assessment online. During that time, they will talk to a Ritzman pharmacist and review their current health and wellness habit as well as their markers of wellness, which will include: hydration, energy, blood pressure, heart rate, weight and blood glucose. Other wellness services include: The RefreshinQ Quotient System, Technology Bar Trainings, point of care testing and an employee wellness program.
The Ritzman Revives program begins with a series of workshops called "Dieting is dead: A better way to approach wellness." A Ritzman pharmacist and registered dietitian lead a discussion about wellness and the future of dieting, including new strategies for starting a wellness program of their own. These workshops are powered by The RefreshinQ Co. and presented in partnership with Erin Schenkenberger.
Attendees will receive coupons, free samples and light snacks.
“In our practices, pharmacists frequently field questions from patients about ways they can boost their energy levels or for help in achieving their wellness goals,” added Beth Husted, general manager pharmacy services, Ritzman. “As part of our mission, this program will individually educate patients on better wellness choices.”
Nature’s Bounty names long-time OTC consumer vet to the helm
NEW YORK — Nature's Bounty on Thursday announced the closing of the transaction with global investment firm, KKR, which is now the majority owner of Nature’s Bounty.
Effective upon the transaction close, consumer healthcare veteran Paul Sturman will assume the role of CEO Nature’s Bounty. Sturman succeeds Steve Cahillane, who is stepping down to pursue another opportunity.
“Paul is a very well regarded leader in the consumer healthcare space, having grown and transformed several companies and brands over the years,” stated Nate Taylor, head of consumer retail at KKR. “He’s a great fit to lead Nature’s Bounty in its next stage of growth.”
“There are tremendous opportunities to grow Nature’s Bounty’s footprint in this rapidly expanding global wellness industry, and I look forward to working with the many talented people at Nature’s Bounty to provide the company’s valued customers with the world’s best health and wellness offerings,” Sturman said.
Sturman has a strong track record of more than 30 years of experience in the consumer healthcare sector with Pfizer, Johnson & Johnson and Warner-Lambert. Sturman spent six years successfully leading Pfizer’s more than $3 billion consumer healthcare business (formerly Wyeth) with major household brands such as Advil, Centrum, Chapstick, Nexium 24Hour, Robitussin and Emergen-C. He also served as president of Johnson & Johnson’s North American Consumer Health Care business, where he was responsible for more than 30 brands including Listerine, Band-Aid, Stayfree, Monistat, Rogaine, Neosporin and Visine.
Sturman also previously served as chairman of the Consumer Health Products Association. He is currently a Trustee of the Foundation for Morristown Medical Center and is on the board of directors of Tyme, a clinical-stage biotechnology company using cellular metabolism and oxidative stress to develop cancer therapeutics with low toxicity profiles.